CH3 BioSystems
Pre-clinicalDevelops synthetic biology platforms for producing sustainable chemicals and materials.
Founded
2015
Focus
Synthetic BiologyMetabolic
About
Develops synthetic biology platforms for producing sustainable chemicals and materials.
Funding History
1Total raised: $2.5M
Seed$2.5MUndisclosedJun 15, 2020
Company Info
TypePrivate
Founded2015
LocationBuffalo, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile